116 related articles for article (PubMed ID: 38339971)
1. C9orf10/Ossa regulates the bone metastasis of established lung adenocarcinoma cell subline H322L-BO4 in a mouse model.
Uekita T; Yagi R; Ichimura T; Sakai R
Genes Cells; 2024 Apr; 29(4):290-300. PubMed ID: 38339971
[TBL] [Abstract][Full Text] [Related]
2. A novel RNA-binding protein, Ossa/C9orf10, regulates activity of Src kinases to protect cells from oxidative stress-induced apoptosis.
Tanaka M; Sasaki K; Kamata R; Hoshino Y; Yanagihara K; Sakai R
Mol Cell Biol; 2009 Jan; 29(2):402-13. PubMed ID: 19015244
[TBL] [Abstract][Full Text] [Related]
3. Early induction of stress-associated Src activator/Homo sapiens chromosome 9 open reading frame 10 protein following photodynamic therapy.
Woźniak M; Hotowy K; Czapińska E; Duś-Szachniewicz K; Szczuka I; Gamian E; Gamian A; Terlecki G; Ziółkowski P
Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):27-33. PubMed ID: 24280438
[TBL] [Abstract][Full Text] [Related]
4. Effect of CUL4A on the metastatic potential of lung adenocarcinoma to the bone.
Cao PP; Chen WJ; Pang HL; Shen WW; Xue P; Duan L; Xu YX; Liu LL; Zhang HL
Oncol Rep; 2020 Feb; 43(2):662-670. PubMed ID: 31894344
[TBL] [Abstract][Full Text] [Related]
5. Anchorage-independent phosphorylation of p130(Cas) protects lung adenocarcinoma cells from anoikis.
Wei L; Yang Y; Zhang X; Yu Q
J Cell Biochem; 2002; 87(4):439-49. PubMed ID: 12397603
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of a novel chinese human lung adenocarcinoma cell line CPA-Yang3 and its real bone metastasis clone CPA-Yang3BM in immunodeficient mice].
Yang S; Shi M; Cao J; Su J; Zhao L; Lei B; Chang C; Lu J; Ye J; Xie W
Zhongguo Fei Ai Za Zhi; 2011 Feb; 14(2):79-85. PubMed ID: 21342638
[TBL] [Abstract][Full Text] [Related]
7. [Establishing the nude mice bone metastasis model of lung adenocarcinoma and applying MicroCT into the observation].
Cui Y; Geng Q; Gu A; Zhu M; Kong H; Sun L; Liu L; Yan M; Yao M
Zhongguo Fei Ai Za Zhi; 2013 Sep; 16(9):452-9. PubMed ID: 24034991
[TBL] [Abstract][Full Text] [Related]
8. CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.
Uekita T; Jia L; Narisawa-Saito M; Yokota J; Kiyono T; Sakai R
Mol Cell Biol; 2007 Nov; 27(21):7649-60. PubMed ID: 17785447
[TBL] [Abstract][Full Text] [Related]
9. SRC tyrosine kinase inhibitor, m475271, suppresses subcutaneous growth and production of lung metastasis via inhibition of proliferation, invasion, and vascularization of human lung adenocarcinoma cells.
Zheng R; Yano S; Matsumori Y; Nakataki E; Muguruma H; Yoshizumi M; Sone S
Clin Exp Metastasis; 2005; 22(3):195-204. PubMed ID: 16158247
[TBL] [Abstract][Full Text] [Related]
10. IL13 Receptor α2 Signaling Requires a Scaffold Protein, FAM120A, to Activate the FAK and PI3K Pathways in Colon Cancer Metastasis.
Bartolomé RA; García-Palmero I; Torres S; López-Lucendo M; Balyasnikova IV; Casal JI
Cancer Res; 2015 Jun; 75(12):2434-44. PubMed ID: 25896327
[TBL] [Abstract][Full Text] [Related]
11. Src-family kinase inhibitors block early steps of caveolin-1-enhanced lung metastasis by melanoma cells.
Ortiz R; Díaz J; Díaz-Valdivia N; Martínez S; Simón L; Contreras P; Lobos-González L; Guerrero S; Leyton L; Quest AFG
Biochem Pharmacol; 2020 Jul; 177():113941. PubMed ID: 32240650
[TBL] [Abstract][Full Text] [Related]
12. p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
Gu MM; Gao D; Yao PA; Yu L; Yang XD; Xing CG; Zhou J; Shang ZF; Li M
Cancer Sci; 2018 Dec; 109(12):3783-3793. PubMed ID: 30281878
[TBL] [Abstract][Full Text] [Related]
13. Metastasis suppressor 1 (MTSS1) expression is associated with reduced in-vivo metastasis and enhanced patient survival in lung adenocarcinoma.
Taylor MD; Bollt O; Iyer SC; Robertson GP
Clin Exp Metastasis; 2018 Feb; 35(1-2):15-23. PubMed ID: 29218652
[TBL] [Abstract][Full Text] [Related]
14. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.
Lee KY; Shueng PW; Chou CM; Lin BX; Lin MH; Kuo DY; Tsai IL; Wu SM; Lin CW
Cancer Sci; 2020 May; 111(5):1652-1662. PubMed ID: 32133706
[TBL] [Abstract][Full Text] [Related]
15. Establishment of an experimental human lung adenocarcinoma cell line SPC-A-1BM with high bone metastases potency by (99m)Tc-MDP bone scintigraphy.
Yang S; Dong Q; Yao M; Shi M; Ye J; Zhao L; Su J; Gu W; Xie W; Wang K; Du Y; Li Y; Huang Y
Nucl Med Biol; 2009 Apr; 36(3):313-21. PubMed ID: 19324277
[TBL] [Abstract][Full Text] [Related]
16. New metastatic model of human small-cell lung cancer by orthotopic transplantation in mice.
Sakamoto S; Inoue H; Ohba S; Kohda Y; Usami I; Masuda T; Kawada M; Nomoto A
Cancer Sci; 2015 Apr; 106(4):367-74. PubMed ID: 25640943
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a human lung cancer cell line with high metastatic potential to multiple organs: gene expression associated with metastatic potential in human lung cancer.
Nakano T; Shimizu K; Kawashima O; Kamiyoshihara M; Kakegawa S; Sugano M; Ibe T; Nagashima T; Kaira K; Sunaga N; Ohtaki Y; Atsumi J; Takeyoshi I
Oncol Rep; 2012 Nov; 28(5):1727-35. PubMed ID: 22922681
[TBL] [Abstract][Full Text] [Related]
18. EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption.
Song X; Cheng X; Jin X; Ruan S; Xu X; Lu F; Wu X; Lu F; Feng M; Zhang L; Ge R; Chen H; Hong Z; Hong D
Clin Exp Metastasis; 2023 Aug; 40(4):357-371. PubMed ID: 37378837
[TBL] [Abstract][Full Text] [Related]
19. Jinfukang regulates integrin/Src pathway and anoikis mediating circulating lung cancer cells migration.
Que ZJ; Yang Y; Liu HT; Shang-Guan WJ; Yu P; Zhu LH; Li HG; Liu HM; Tian JH
J Ethnopharmacol; 2021 Mar; 267():113473. PubMed ID: 33068649
[TBL] [Abstract][Full Text] [Related]
20. Blocking MMP-12-modulated epithelial-mesenchymal transition by repurposing penfluridol restrains lung adenocarcinoma metastasis via uPA/uPAR/TGF-β/Akt pathway.
Hung WY; Lee WJ; Cheng GZ; Tsai CH; Yang YC; Lai TC; Chen JQ; Chung CL; Chang JH; Chien MH
Cell Oncol (Dordr); 2021 Oct; 44(5):1087-1103. PubMed ID: 34319576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
